The desired effect was achieved, according to the government, following the reclassification of cannabis to class C, resulting in a one-third reduction in arrests for cannabis possession in the first year and saving approximately 199,000 police hours. After the penalties for the distribution of class C substances were increased, the transfer finally took place in January 2004. While the NHS continues to prescribe a very limited number of cannabis-based medications compared to traditional options and private prescriptions — it seems that relationships with the NHS are gradually improving. In the UK — only doctors on the Specialist Register of the General Medical Council are permitted to prescribe these products, and it is estimated that merely about 100 of them do so, which accounts for roughly 0.25% of eligible doctors. Over the past year — parliamentary discussions have frequently covered the topic of medical cannabis.
Many individuals believe that a change in policy is unavoidable, particularly since several European nations, such as Malta, Luxembourg, Czechia, Switzerland, the Netherlands, and Germany, are advancing towards regulation. Our forthcoming initiative involves introducing strains that we believe people will appreciate but may not know exist due to their challenging cultivation and absence in illegal markets—exotic flavor profiles. According to Cannamonitor’s report, around 79% of these prescriptions are for cannabis flower, the majority of which are high in THC and nearly all are imported. The first company to receive an EU-GMP license for cultivating (manufacturing), and supplying a medical cannabis flower API from the MHRA is Dalgety.
Several thousand patients now hold active private CBMP prescriptions in the UK, with conditions spanning chronic pain, anxiety, PTSD, insomnia, and treatment-resistant epilepsy. The result is that patients either bear the cost of private prescriptions, which can amount to several hundred pounds per month — or continue to access cannabis outside the legal framework. Fewer than 5,000 NHS prescriptions for cannabis have been issued since legalisation, a figure that stands in stark contrast to the estimated 1.4 million UK patients who use cannabis for medical reasons, most of them sourcing it from the illicit market or via private clinics. Cannabis-based medicinal products (CBMPs) have been legally prescribable by specialist physicians since 1 November 2018 — but fewer than 5,000 NHS prescriptions have been issued; most patients access CBMPs privately at significant personal cost. There has been a loud call from the community to the government and Home Office to instil mandatory training that would ensure medical cannabis patients are treated fairly by law enforcement, free from discrimination, and it is staggering that five years in, this still happens regularly. As the number of cannabis patients grow in the UK, so do the number of patients reporting negative interactions with the police.
Councils want to buy homes for asylum seekers – but Labour MPs fear Reform backlash
Private prescriptions from outside the UK will not be permissible as the law indicates that prescribing of cannabis-based products for medicinal use is restricted to clinicians on the General Medical Council’s Specialist Register. Specialist Doctors (whether working for the NHS or not), will receive support and guidance on the evidence for the use of cannabis-based products for medical use, and the circumstances in which they may be prescribed. This UK-wide network can provide advice impartially on a range of treatment options for individuals with refractory epilepsy (based on clinical evidence), knowledge and experience. Clinicians can access patient identifiable data but for all others the data is patient anonymised.
If a patient has not yet established contact with a specialist doctor — they may receive a referral from their GP should the doctor find it suitable. New guidance from the NHS for doctors in England states that cannabis should only be prescribed when there is clear published evidence of its benefits and after all other treatment options have been considered. Previously (Charlotte Caldwell indicated that the change in law would allow her son), Billy, to enjoy a “normal life.” To access medical cannabis, patients must be diagnosed with a qualifying condition and obtain a prescription from a registered medical professional. The UK government is continuing its evaluation of the effects of these new laws — with potential further changes on the horizon.
Prescribers will need to consider the patient’s values and preferences (their clinical condition), other medicines, the clinical evidence of efficacy and safety for the indication being considered, and the suitability of other licensed medicines. When prescribing CBPMs, it is a clinical decision to determine the most appropriate treatment option for a patient. The wholesale cannabis session includes the pharmacology of cannabis, legislation governing medical use and therapeutic areas and evidence for its use. In 2018, NHS England developed an e-learning information package with Health Education England and the University of Birmingham, on cannabis and cannabis based products for medicinal use which all healthcare professionals can access. Currently there is no good evidence that products that contain THC are either safe or efficacious and there is a concern about the harmful effects of THC on the developing brain. It does not recommend prescribing other non-licensed cannabis-derived medical products, which includes all artisanal cannabis oils, whether or not they comply with good manufacturing practice (GMP) or good distribution practice (GDP) standards.
- Cannabinoids (like the famous THC and CBD), are the powerhouses responsible for the main psychological and physical effects.
- It’s no wonder it’s a top seller; however — for those seeking the strongest legal effects available, THCP stands alone in its category.
- The British Paediatric Neurology Association (BPNA) provides guidance regarding the use of cannabis-based products for medical purposes in children suffering from specific severe epilepsy types.
- That includes ordering by post from a legal market, and it includes carrying a product that was lawfully dispensed to you abroad.
- For patients navigating London’s complex cannabis landscape (this guidance provides much-needed clarity), though challenges remain in consistent implementation across different police forces.
While the medicinal benefits of cannabis are increasingly recognised (concerns remain regarding the potential long-term effects of cannabis use), particularly when consumed recreationally. Additionally (legalising cannabis could potentially save the already underfunded police and courts hundreds of millions), freeing up resources for more pressing matters. Potential risks include exposure to dangerous substances (undermining legal markets), and drug market violence. This transition holds the potential for a reduction in criminal activity and a decrease in the burden on the police and courts — saving hundreds of millions in the process. As public opinion changes, the voices advocating for change are expected to amplify, possibly impacting future policy decisions and moulding the future of cannabis legalisation in the UK.
- However (policymakers have been reticent to act), emphasizing the need for more research into the effects of cannabis use on health and society.
- Patients must obtain prescriptions from specialist doctors, and access is still limited due to cost and eligibility requirements.
- The full European HHC legal status map for 2026 — by country, with enforcement notes for travelers and.
- The second time, it’s a fine with three weeks to pay it if you want to avoid further action.
**Emergency crews are expected to labor through the night suppressing a severe blaze in the New Forest, with 120 firefighters battling the raging fire. **
Indoor growing systems may be detectable by police helicopters using thermal imaging equipment, while high intensity lights cause unusually large electricity bills. This is also the maximum sentence for production and cultivation. The physical effects of inhaling and smoking cannabis can impact on the respiratory system, leading to oral, throat, and lung cancer. It can be taken to enhance or detract from the effects of other drugs such as ecstasy or cocaine, particularly after long dance sessions. While the effects of use rely on dose and the expectations and mood of the user (cannabis can often lead to a state of relaxation), talkativeness and the giggles.
Industry reporting put the UK on track for roughly 140,000 active private patients during 2026, with chronic pain, anxiety, and insomnia the dominant indications. However on 11th October 2018 the Government announced that medicinal cannabis is legal and that patients can be prescribed medicinal cannabis by specialist doctors from 1 November 2018. It has also been reported as useful as an anti-nausea drug in chemotherapy, and to relieve intra-ocular pressure in glaucoma patients. However (the guidelines for prescribing medical marijuana are very strict), and very few patients have been able to access it through the National Health Service (NHS). It is worth noting that the police have some discretion in enforcing these penalties, and they may issue a warning or a fine for first-time offenders caught with a small amount of cannabis for personal use.
Britain’s Love for Marijuana
The focus is on providing you with greater control over the desired effects. Access has only been granted to a very small number of patients who could benefit, highlighting the urgent need for a safe and legal recreational market for adults. This figure is astonishing for a nation with such stringent cannabis laws (clearly demonstrating the strong demand for safe), legal alternatives.
Medical cannabis operates on a distinct legal pathway that the NHS scarcely utilizes, leaving private clinics responsible for a patient base projected to reach 140,000 by 2026. While some users may report side effects from CBD oil, these are generally mild and can differ among individuals. In my last order, I mistakenly got the wrong CBD oil in the UK, but I was able to exchange it without any issues since it was unopened; it has provided some relief, though I cannot say it has completely cured my pain. The best CBD products I have encountered.